Search results
Showing 1 to 15 of 52 results for ng191
This guideline covers managing COVID-19 in babies, children, young people and adults in community and hospital settings. It includes recommendations on communication, assessment, therapeutics for COVID-19, non-invasive respiratory support, preventing and managing acute complications, and identifying and managing co-infections.
Dexamethasone and hydrocortisone are both corticosteroids; they have a role in treating COVID-19 in certain people.
Recommendation ID NG191/13 Question What are the views, preferences and experiences of people with COVID-19-associated pulmonary...
Recommendation ID NG191/6 Question Does a multidisciplinary team agreed approach to weaning from continuous positive airway pressure...
Recommendation ID NG191/7 Question What is the effectiveness, cost effectiveness and safety of using a combination of casirivimab and...
Recommendation ID NG191/9 Question What is the clinical and cost effectiveness of budesonide for treating COVID-19 in the community in
Recommendation ID NG191/3 Question What is the effectiveness and safety of a treatment dose with a low molecular weight heparin (LMWHs)
Recommendation ID NG191/4 Question Does early review and referral to specialist palliative care services improve outcomes for adults with
Recommendation ID NG191/10 Question What risk factors in people who are critically ill and have, or have had, COVID-19 as part of their
Recommendation ID NG191/2 Question What is the effectiveness and safety of extended pharmacological venous thromboembolism (VTE)...
Recommendation ID NG191/15 Question What is the effectiveness and safety of neutralising monoclonal antibodies against different...
Recommendation ID NG191/12 Question In people with suspected COVID-19-associated pulmonary aspergillosis (CAPA), what are the most...
Recommendation ID NG191/5 Question Is high-flow nasal oxygen effective in reducing breathlessness compared with standard care or...
Recommendation ID NG191/8 Question What is the effectiveness, cost effectiveness and safety of the combination of casirivimab and...
Recommendation ID NG191/1 Question What is the effectiveness and safety of standard-dose compared with intermediate-dose pharmacological